Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.36 EUR
47.25 M EUR
118.97 M EUR
18.48 M
About Ligand Pharmaceuticals Incorporated
Sector
CEO
Todd C. Davis
Headquarters
Jupiter
Website
Founded
1987
FIGI
BBG000BMKM16
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LGDN is 103.00 EUR — it hasn't changed in the past 24 hours. Watch LIGAND PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange LIGAND PHARMACEUTICALS INC stocks are traded under the ticker LGDN.
LGDN stock has risen by 1.90% compared to the previous week, the month change is a −4.46% fall, over the last year LIGAND PHARMACEUTICALS INC has showed a 53.73% increase.
We've gathered analysts' opinions on LIGAND PHARMACEUTICALS INC future price: according to them, LGDN price has a max estimate of 154.56 EUR and a min estimate of 120.75 EUR. Watch LGDN chart and read a more detailed LIGAND PHARMACEUTICALS INC stock forecast: see what analysts think of LIGAND PHARMACEUTICALS INC and suggest that you do with its stocks.
LGDN reached its all-time high on Oct 1, 2018 with the price of 175.78 EUR, and its all-time low was 0.78 EUR and was reached on Nov 22, 2010. View more price dynamics on LGDN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LGDN stock is 4.90% volatile and has beta coefficient of 1.23. Track LIGAND PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is LIGAND PHARMACEUTICALS INC there?
Today LIGAND PHARMACEUTICALS INC has the market capitalization of 2.03 B, it has decreased by −5.04% over the last week.
Yes, you can track LIGAND PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
LIGAND PHARMACEUTICALS INC is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
LGDN earnings for the last quarter are 1.65 EUR per share, whereas the estimation was 1.21 EUR resulting in a 36.59% surprise. The estimated earnings for the next quarter are 1.15 EUR per share. See more details about LIGAND PHARMACEUTICALS INC earnings.
LIGAND PHARMACEUTICALS INC revenue for the last quarter amounts to 46.53 M EUR, despite the estimated figure of 36.46 M EUR. In the next quarter, revenue is expected to reach 37.70 M EUR.
LGDN net income for the last quarter is −6.44 M EUR, while the quarter before that showed −48.46 M EUR of net income which accounts for 86.71% change. Track more LIGAND PHARMACEUTICALS INC financial stats to get the full picture.
No, LGDN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 10, 2025, the company has 58.00 employees. See our rating of the largest employees — is LIGAND PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LIGAND PHARMACEUTICALS INC EBITDA is 49.91 M EUR, and current EBITDA margin is 35.97%. See more stats in LIGAND PHARMACEUTICALS INC financial statements.
Like other stocks, LGDN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIGAND PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LIGAND PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LIGAND PHARMACEUTICALS INC stock shows the buy signal. See more of LIGAND PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.